-+ 0.00%
-+ 0.00%
-+ 0.00%

BIO-key shares suspended on Nasdaq after close, shift to OTC Markets May 13

PUBT·05/12/2026 20:01:27
Listen to the news
BIO-key shares suspended on Nasdaq after close, shift to OTC Markets May 13
  • BIO-key received Nasdaq notice that trading of its common stock on Nasdaq will be suspended effective with today’s market close.
  • Suspension tied to failure to meet Nasdaq $1 minimum bid-price compliance by May 4, despite shares trading above $1 for eight consecutive sessions following a 1-for-10 reverse split that took effect April 30.
  • Nasdaq also cited delinquency in filing annual report on Form 10-K for year ended Dec. 31, 2025.
  • Common stock expected to move to OTC Markets quotation under symbol BKYI starting May 13.
  • BIO-key plans to request hearing before Nasdaq Hearings Panel seeking reinstatement of trading on Nasdaq Capital Market.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BIO-key International Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605121601PRIMZONEFULLFEED9718739) on May 12, 2026, and is solely responsible for the information contained therein.